Acilde Nontravmatik Spinal Hastalıklar: Tanı ve Tedavi

Buzzell A, Chamberlain JD, Gmünder HP, et al. Survival after non-traumatic spinal cord injury: evidence from a population-based rehabilitation cohort in Switzerland. Spinal Cord. 2019;57(4):267-275. doi: 10.1038/s41393-018-0212-x

Grassner L, Marschallinger J, Dünser MW, et al. Nontraumatic spinal cord injury at the neurological intensive care unit: spectrum, causes of admission and predictors of mortality. Ther Adv Neurol Disord. 2016;9(2):85-94. doi: 10.1177/1756285615621687

Musubire AK, Meya DB, Katabira ET, et al. Epidemiology of non-traumatic spinal cord injury in Uganda: a single center, prospective study with MRI evaluation. BMC Neurol. 2019;19(1):10. doi: 10.1186/s12883-019-1236-3

Smith É, Fitzpatrick P, Lyons F, et al. Epidemiology of non- traumatic spinal cord injury in Ireland - a prospective population-based study. J Spinal Cord Med. 2022;45(1):76-81. doi: 10.1080/10790268.2020.1762829

New PW, Rawicki HB, Bailey MJ. Nontraumatic spinal cord injury: demographic characteristics and complications. Arch Phys Med Rehabil. 2002;83(7):996-1001. doi: 10.1053/apmr.2002.33100

Ohry A, Brooks ME, Rozin R. Misdiagnosis of spinal cord injuries—the physiatrist's point of view. Paraplegia. 1980;18(1):15-20. doi: 10.1038/sc.1980.3

Pikija S, Mutzenbach JS, Kunz AB, et al. Delayed Hospital Presentation and Neuroimaging in Non-surgical Spinal Cord Infarction. Front Neurol. 2017;8:143. doi: 10.3389/fneur.2017.00143

Rittenberg JD, Burns SP, Little JW. Worsening myelopathy masked by peripheral nerve disorders. J Spinal Cord Med. 2004;27(1):72-77. doi: 10.1080/10790268.2004.11753733

Müller-Jensen L, Ploner CJ, Kroneberg D, et al. Clinical Presentation and Causes of Non-traumatic Spinal Cord Injury: An Observational Study in Emergency Patients. Front Neurol. 2021;12:701927. doi: 10.3389/fneur.2021.701927

Hui AC, Wong KS, Fu M, et al. Ischaemic myelopathy presenting as Guillain- Barré syndrome. Int J Clin Pract. 2000;54(5):340-341.

Jellema K, Tijssen CC, van Gijn J. Spinal dural arteriovenous fistulas: a congestive myelopathy that initially mimics a peripheral nerve disorder. Brain. 2006;129:3150-3164. doi: 10.1093/brain/awl220

Kondo A, Yamaguchi H, Ishida Y, et al. Spontaneous spinal epidural hematoma mimicking Guillain-Barre Syndrome. Brain Dev. 2019;41(4):392-395. doi: 10.1016/j.braindev.2018.11.004

Scelsa SN. Syringomyelia presenting as ulnar neuropathy at the elbow. Clin Neurophysiol. 2000;111(9):1527-1530. doi: 10.1016/s1388-2457(00)00361-8

Heruti RJ, Reznik J, Adunski A, et al. Conversion motor paralysis disorder: analysis of 34 consecutive referrals. Spinal Cord. 2002;40(7):335-340. doi: 10.1038/sj.sc.3101307

Karmacharya P, Poudel DR, Pathak R, et al. Acute hyperkalemia leading to flaccid paralysis: a review of hyperkalemic manifestations. J Community Hosp Intern Med Perspect. 2015;5(3):27993. doi: 10.3402/jchimp.v5.27993

Ptaszynski AE, Hooten WM, Huntoon MA. The incidence of spontaneous epidural abscess in Olmsted County from 1990 through 2000: a rare cause of spinal pain. Pain Med. 2007;8(4):338-343. doi: 10.1111/j.1526-4637.2006.00173.x

Pradilla G, Ardila GP, Hsu W, et al. Epidural abscesses of the CNS. Lancet Neurol. 2009;8(3):292-300. doi: 10.1016/S1474-4422(09)70044-4

Barron KD, Hirano A, Araki S, et al. Experiences with metastatic neoplasms involving the spinal cord. Neurology. 1959;9(2):91-106. doi: 10.1212/wnl.9.2.91

Flanagan EP, Pittock SJ. Diagnosis and management of spinal cord emergencies. Handb Clin Neurol. 2017;140:319-335. doi: 10.1016/B978-0-444-63600-3.00017-9

Flanagan EP, Cabre P, Weinshenker BG, et al. Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum. Ann Neurol. 2016;79(5):775-783. doi: 10.1002/ana.24617

Darouiche RO. Spinal epidural abscess. N Engl J Med. 2006;355(19):2012-2020. doi: 10.1056/NEJMra055111

Blacker DJ, Wijdicks EF, Ramakrishna G. Resolution of severe paraplegia due to aortic dissection after CSF drainage. Neurology. 2003;61(1):142-143. doi: 10.1212/01.wnl.0000068526.26685.22

Flanagan EP, McKeon A, Weinshenker BG. Anterior spinal artery infarction causing man-in-the-barrel syndrome. Neurol Clin Pract. 2014;4(3):268-269. doi: 10.1212/CPJ.0000000000000032

Gaul C, Dietrich W, Erbguth FJ. Neurological symptoms in aortic dissection: a challenge for neurologists. Cerebrovasc Dis. 2008;26(1):1-8. doi: 10.1159/000135646

Cheung AT, Pochettino A, McGarvey ML, et al. Strategies to manage paraplegia risk after endovascular stent repair of descending thoracic aortic aneurysms. Ann Thorac Surg. 2005;80(4):1280-1288; discussion 1288-1289. doi: 10.1016/j.athoracsur.2005.04.027

Restrepo L, Guttin JF. Acute spinal cord ischemia during aortography treated with intravenous thrombolytic therapy. Tex Heart Inst J. 2006;33(1):74-77.

Fugate JE, Lanzino G, Rabinstein AA. Clinical presentation and prognostic factors of spinal dural arteriovenous fistulas: an overview. Neurosurg Focus. 2012;32(5):E17. doi: 10.3171/2012.1.FOCUS11376

Rabinstein AA. Vascular myelopathies. Continuum (Minneap Minn). 2015;21(1 Spinal Cord Disorders):67-83. doi: 10.1212/01.CON.0000461085.79241.e0

Cole JS, Patchell RA. Metastatic epidural spinal cord compression. Lancet Neurol. 2008;7(5):459-466. doi: 10.1016/S1474-4422(08)70089-9

Sørensen S, Helweg-Larsen S, Mouridsen H, et al. Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. Eur J Cancer. 1994;30A(1):22-27. doi: 10.1016/s0959-8049(05)80011-5

Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002;125(Pt 7):1450-1461. doi: 10.1093/brain/awf151

Hinson SR, McKeon A, Fryer JP, et al. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Arch Neurol. 2009;66(9):1164-1167. doi: 10.1001/archneurol.2009.188

Hinson SR, Romero MF, Popescu BF, et al. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci U S A. 2012;109(4):1245-1250. doi: 10.1073/pnas.1109980108

Chihara N, Aranami T, Sato W, et al. Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. Proc Natl Acad Sci U S A. 2011;108(9):3701-3706. doi: 10.1073/pnas.1017385108

Flanagan EP, Weinshenker BG. Neuromyelitis optica spectrum disorders. Curr Neurol Neurosci Rep. 2014;14(9):483. doi: 10.1007/s11910-014-0483-3

Pittock SJ, Lennon VA, McKeon A, et al. Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol. 2013;12(6):554-562. doi: 10.1016/S1474-4422(13)70076-0

Araki M, Matsuoka T, Miyamoto K, et al. Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. Neurology. 2014;82(15):1302-1306. doi: 10.1212/WNL.0000000000000317

McKeon A, Lennon VA, Lotze T, et al. CNS aquaporin-4 autoimmunity in children. Neurology. 2008;71(2):93-100. doi: 10.1212/01.wnl.0000314832.24682.c6

Misu T, Sato DK, Nakashima I, et al. MOG-IgG serological status matters in paediatric ADEM. J Neurol Neurosurg Psychiatry. 2015;86(3):242. doi: 10.1136/jnnp-2014-308723

Flanagan EP, Kaufmann TJ, Krecke KN, et al. Discriminating long myelitis of neuromyelitis optica from sarcoidosis. Ann Neurol. 2016;79(3):437-447. doi: 10.1002/ana.24582

Flanagan EP, Weinshenker BG, Krecke KN, et al. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol. 2015;72(1):81-87. doi: 10.1001/jamaneurol.2014.2137

Hyun JW, Kim SH, Jeong IH, et al. Bright spotty lesions on the spinal cord: an additional MRI indicator of neuromyelitis optica spectrum disorder? J Neurol Neurosurg Psychiatry. 2015;86(11):1280-1282. doi: 10.1136/jnnp-2014-309761

Kitley J, Waters P, Woodhall M, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol. 2014;71(3):276-283. doi: 10.1001/jamaneurol.2013.5857.

Urai Y, Matsumoto K, Shimamura M, et al. Paraneoplastic necrotizing myelopathy in a patient with advanced esophageal cancer: An autopsied case report. J Neurol Sci. 2009;280(1-2):113-117. doi: 10.1016/j.jns.2009.02.324

Flanagan EP, McKeon A, Lennon VA, et al. Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology. 2011;76(24):2089-2095. doi: 10.1212/WNL.0b013e31821f468f

Weinshenker BG, O'Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999;46(6):878-886. doi: 10.1002/1531-8249(199912)46:6<878::aid- ana10>3.0.co;2-q

Kleiter I, Gahlen A, Borisow N, et al. Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses. Ann Neurol. 2016;79(2):206-216. doi: 10.1002/ana.24554

Weinshenker BG. What Is the Optimal Sequence of Rescue Treatments for Attacks of Neuromyelitis Optica Spectrum Disorder? Ann Neurol. 2016;79(2):204-205. doi: 10.1002/ana.24557.

Kim SM, Go MJ, Sung JJ, et al. Painful tonic spasm in neuromyelitis optica: incidence, diagnostic utility, and clinical characteristics. Arch Neurol. 2012;69(8):1026-1031. doi: 10.1001/archneurol.2012.112

Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006;63(3):390-396. doi: 10.1001/archneur.63.3.390

Brex PA, Ciccarelli O, O'Riordan JI, et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med. 2002;346(3):158-164. doi: 10.1056/NEJMoa011341

McKeon A, Apiwattanakul M, Lachance DH, et al. Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. Arch Neurol. 2010;67(3):322-329. doi: 10.1001/archneurol.2009.336

Flanagan EP, O'Neill BP, Porter AB, et al. Primary intramedullary spinal cord lymphoma. Neurology. 2011;77(8):784-791. doi: 10.1212/WNL.0b013e31822b00b9